Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.
公式(I)的化合物或其药学上可接受的盐是GPCR激动剂,并可用于治疗肥胖症和糖尿病。
Piperidine GPCR agonists
申请人:Prosidion Limited
公开号:EP2377863A1
公开(公告)日:2011-10-19
Compounds of formula (I):
or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.
式(I)化合物:
或其药学上可接受的盐类是 GPCR 激动剂,可用于治疗肥胖症和糖尿病。
PIPERIDINE GPCR AGONISTS
申请人:Prosidion Limited
公开号:EP2114933A1
公开(公告)日:2009-11-11
[EN] PIPERIDINE GPCR AGONISTS<br/>[FR] AGONISTES DU GPCR DE PIPÉRIDINE
申请人:PROSIDION LTD
公开号:WO2008081204A1
公开(公告)日:2008-07-10
[EN] Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes. [FR] L'invention porte sur des composés de formule (I) ou leurs sels pharmacocompatibles, agonistes du GPCR, servant à traiter le diabete et l'obésité.